Navigation Links
DURECT to Present at BIO CEO Investor Conference 2008
Date:2/4/2008

CUPERTINO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matthew J. Hogan, Chief Financial Officer, will be presenting at the BIO CEO and Investor Conference to be held at the Waldorf Astoria Hotel in New York on February 11, 2008 at 11:45 a.m. Eastern Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations". If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. DURECT to Present at 2007 BIO Investor Forum
2. DURECT to Present at UBS Global Life Sciences Conference
3. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
4. BIO CEO & Investor 2008 Conference to Webcast Millennium Presentation
5. Bush Budget Represents Double Whammy Hit on U.S. Seniors Medicare-Financed Nursing Facility Care
6. Linda Ellerbee to Present Keynote at URACs Best Practices in Consumer Empowerment and Protection Awards Program
7. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
8. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
9. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
10. Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity
11. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...alth System say the federal government could promo...ive manner that would ultimately save lives. They ...rt a Flu vaccination programme, //by direct advert...cal companies. They are hoping to target individu...
...BCC-5) had doctors, nurses, patients and advocates...ient care//. Breast cancer is the most common canc...l rates are improving. The event was conducted by...th each other. The European Breast Cancer Coalitio...
...becoming apparent to the Government Health officia...is now pulling up// its socks and gearing up to ta...s, or directly observed treatment, short-course, a...by the World Health Organization and its partners,...
... noted in Europe, following the reduction in numbe...hift of the media coverage // to other important s...ion of consumer fears about bird flu. Although p...resent a pathetic picture, the overall situation s...
Other Medicine News:Health News:Influenza Vaccination For The Elderly 2
(Date:10/7/2008)... 7 /- A study published in the,scient...self-renewal,reported that InVitria,s ( http://ww...m albumin) was an effective replacement to bovine ...titled, "The ground state of embryonic stem cell,s...astim as a recombinant,albumin in place of animal-...
(Date:10/7/2008).../- Aerovance Inc. today reported,phar...ial of its Aerovant,inhalation powder that demonst...rritancy following asthma patients, inhalation of ... highest of three doses investigated in,Aerovance,... to begin early,next year. Evidence gathered from ...
(Date:10/7/2008)...wire-FirstCall/ -- Ardea Biosciences, Inc.,(Nasdaq...RDEA119, a Potent,and Highly Selective MEK1/2 Inhi...) -- induced Chronic Colitis in Mice," was present...G) 2008 Annual Meeting in Orlando,Florida. The po... of,RDEA119, the Company,s lead mitogen-activated ...
(Date:10/7/2008)...ber 7 /-, - 125 Patient, P...Study,Shows Statistically Significant Improved Ove...the mature phase II data from the,therapeutic pros...d been,obtained as part of the recently entered pa... in the US., The results from the Phase II prospe...
Breaking Medicine Technology:Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5Sorafenib Shows Promise for Heart Lung Disease 19870 1Sorafenib Shows Promise for Heart Lung Disease 19870 2SleepQuest Holds Open House 19866 1SleepQuest Holds Open House 19866 2Caraco Pharmaceutical Laboratories Ltd to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29 2008 19861 1Caraco Pharmaceutical Laboratories Ltd to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29 2008 19861 2Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on Zero Tolerance for Hepatitis B 5537 1Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on Zero Tolerance for Hepatitis B 5537 2
...--May 29, 2007 - Introgen,Therapeutics, Inc. (NASD...will report updated Phase 2 clinical trial results... the upcoming,annual meetings of The American Soci... American Society of Gene Therapy (ASGT) in,Seattl...ine of,first-in-class cancer therapies generating ...
...29, 2007 - Mitopharm Corporation,Inc. (Pink Sheet...where Professor Dr. Robert Ko published the benefi...) Schisandrin B - a novel,discovery by Dr. Ko - on...tled "SCHISANDRIN B PROTECTS AGAINST,MYOCARDIAL IS...GLUTATHIONE ANTIOXIDANT STATUS"; Yim and Ko; Molec...
Other Medicine Technology:Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 3Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 2Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 3
Features soft, low friction sheath that extends beyond the tip.
Designed to retain the desired curve during oral intubation.
Facilitates intubation of tracheal tubes.
SunGlide™ Stylette - Grey Child. Use in 4.0 to 7mm tubes. 25/box.
Medicine Products: